Evidence map›Paper›PMID 40863371›Full record

ArticleJournal of cardiovascular development and disease2025

Coronary Artery Calcification in Patients with Radiographic Axial Spondyloarthritis: A Comparative Study with Matched Controls in Southwestern Sweden.

Erik Hulander, Anna Deminger, Sofia Enegren, Magnus Hallström, Caroline Feldthusen, Erika Fagman, Oskar Angerås, Tatiana Zverkova Sandström, Mats Geijer, Helena Forsblad-d'Elia

Abstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Erik HulanderDepartment of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.ORCID 0000-0003-3416-2748
Anna DemingerDepartment of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.ORCID 0000-0001-6423-1623
Sofia EnegrenDepartment of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.
Magnus HallströmDepartment of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.ORCID 0009-0009-4430-0228
Caroline FeldthusenDepartment of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.ORCID 0000-0003-3467-6757
Erika FagmanDepartment of Radiology, Region Västra Götaland, Sahlgrenska University Hospital, 41685 Gothenburg, Sweden.ORCID 0000-0002-0983-0313
Oskar AngeråsDepartment of Cardiology, Region Västra Götaland, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.ORCID 0000-0002-3474-2438
Tatiana Zverkova SandströmDepartment of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.
Mats GeijerDepartment of Radiology, Region Västra Götaland, Sahlgrenska University Hospital, 41685 Gothenburg, Sweden.ORCID 0000-0003-0529-7723
Helena Forsblad-d'EliaDepartment of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.

Funding

King Gustaf Vth 80- year Foundation FAI-2017-0454Rune och Ulla Amlövs Foundation 2023-408Swedish Rheumatism Association in GothenburgThe Felix Neubergh's FoundationThe Margareta Rheuma research foundationthe Sahlgrenska University Hospitals Research FoundationsThe Swedish Research Council 2016-02035The Swedish Rheumatism Associationthe Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement ALFVLL-640251, ALFGBG-938395, ALFGBG-965333The Wilhelm and Martina Lundgren Science Foundation 2024-GU-4712
6 · The paper itself

Abstract

Radiographic axial spondyloarthritis (r-axSpA) is associated with increased cardiovascular disease (CVD) risk. The coronary artery calcification (CAC) score, an atherosclerosis burden indicator that predicts CVD risk, is not well studied in r-axSpA. This study investigates CAC scores in patients with r-axSpA compared to controls without rheumatic disease and factors associated with CAC scores in r-axSpA patients. Fifty-eight r-axSpA patients from southwestern Sweden were assessed cross-sectionally using clinical disease measures, physical function, spinal mobility, lipid profiles, inflammation markers, and long-term time-averaged C-reactive protein (CRP). Four controls per patient were selected from the Swedish CArdioPulmonary bioImage Study (SCAPIS). CAC was scored on cardiac computed tomography (CT) using the Agatston method. The presence of CAC in the right coronary artery (RCA) was higher in patients compared to controls. However, no significant difference in total CAC scores was observed between r-axSpA patients and controls, despite numerically higher total CAC scores in patients. In r-axSpA patients, CAC scores correlated positively with time-averaged CRP, reduced physical function, and impaired spinal mobility. These findings suggest that chronic inflammation may contribute to coronary calcification and CVD risk in r-axSpA, highlighting the need for effective anti-inflammatory treatments. Further research is warranted to explore the association between coronary calcification, spinal immobility, and limitations in physical function.

Indexed as

cardiovascular disease riskchronic inflammationcoronary artery calcificationradiographic axial spondyloarthritis

Identifiers

PMID40863371
PMCPMC12387049

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.